» Articles » PMID: 22384431

An Update of Preimplantation Genetic Diagnosis in Gene Diseases, Chromosomal Translocation, and Aneuploidy Screening

Overview
Date 2012 Mar 3
PMID 22384431
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Preimplantation genetic diagnosis (PGD) is gradually widely used in prevention of gene diseases and chromosomal abnormalities. Much improvement has been achieved in biopsy technique and molecular diagnosis. Blastocyst biopsy can increase diagnostic accuracy and reduce allele dropout. It is cost-effective and currently plays an important role. Whole genome amplification permits subsequent individual detection of multiple gene loci and screening all 23 pairs of chromosomes. For PGD of chromosomal translocation, fluorescence in-situ hybridization (FISH) is traditionally used, but with technical difficulty. Array comparative genomic hybridization (CGH) can detect translocation and 23 pairs of chromosomes that may replace FISH. Single nucleotide polymorphisms array with haplotyping can further distinguish between normal chromosomes and balanced translocation. PGD may shorten time to conceive and reduce miscarriage for patients with chromosomal translocation. PGD has a potential value for mitochondrial diseases. Preimplantation genetic haplotyping has been applied for unknown mutation sites of single gene disease. Preimplantation genetic screening (PGS) using limited FISH probes in the cleavage-stage embryo did not increase live birth rates for patients with advanced maternal age, unexplained recurrent abortions, and repeated implantation failure. Polar body and blastocyst biopsy may circumvent the problem of mosaicism. PGS using blastocyst biopsy and array CGH is encouraging and merit further studies. Cryopreservation of biopsied blastocysts instead of fresh transfer permits sufficient time for transportation and genetic analysis. Cryopreservation of embryos may avoid ovarian hyperstimulation syndrome and possible suboptimal endometrium.

Citing Articles

Update on genetic screening and treatment for infertile men with genetic disorders in the era of assisted reproductive technology.

Lee S, Lee T, Song S, Kim D, Choi K, Lee J Clin Exp Reprod Med. 2021; 48(4):283-294.

PMID: 34875735 PMC: 8651766. DOI: 10.5653/cerm.2021.04476.


The Clinical Effectiveness of Preimplantation Genetic Diagnosis for Chromosomal Translocation Carriers: A Meta-analysis.

Mahdavi M, Sharafi S, Daniali S, Riahi R, Kheirollahi M Glob Med Genet. 2020; 7(1):14-21.

PMID: 32879919 PMC: 7410090. DOI: 10.1055/s-0040-1712455.


Preimplantation Genetic Screening and The Success Rate of Fertilization: A Three-Years Study on Iranian Population.

Totonchi M, Babaabasi B, Najafi H, Rezazadeh Valojerdi M, Eftekhari-Yazdi P, Karimian L Cell J. 2020; 22(4):467-475.

PMID: 32347040 PMC: 7211278. DOI: 10.22074/cellj.2021.6784.


Clinical application of oligo array-CGH for detecting balanced translocations in preimplantation genetic diagnosis.

Zhou Z, Ma Y, Li Q, Zhang Y, Huang Y, Tu Z Int J Clin Exp Pathol. 2020; 10(7):7821-7835.

PMID: 31966630 PMC: 6965244.


Associations of recurrent miscarriages with chromosomal abnormalities, thrombophilia allelic polymorphisms and/or consanguinity in Saudi Arabia.

Turki R, Assidi M, Banni H, Zahed H, Karim S, Schulten H BMC Med Genet. 2016; 17(Suppl 1):69.

PMID: 27766963 PMC: 5073987. DOI: 10.1186/s12881-016-0331-1.


References
1.
Wu C, Lin S, Su Y, Fang M, Chen S, Hsu C . Preimplantation genetic diagnosis (embryo screening) for enlarged vestibular aqueduct due to SLC26A4 mutation. Audiol Neurootol. 2010; 15(5):311-7. DOI: 10.1159/000284349. View

2.
Chen S, Chen C, Yang Y . Ovarian hyperstimulation syndrome (OHSS): new strategies of prevention and treatment. J Formos Med Assoc. 2008; 107(7):509-12. DOI: 10.1016/s0929-6646(08)60162-x. View

3.
Qubbaj W, Al-Swaid A, Al-Hassan S, Awartani K, Deek H, Coskun S . First successful application of preimplantation genetic diagnosis and haplotyping for congenital hyperinsulinism. Reprod Biomed Online. 2010; 22(1):72-9. DOI: 10.1016/j.rbmo.2010.09.016. View

4.
. Guidelines for good practice in PGD: programme requirements and laboratory quality assurance. Reprod Biomed Online. 2008; 16(1):134-47. DOI: 10.1016/s1472-6483(10)60567-6. View

5.
Chen C, Wu M, Chao K, Lien Y, Chen S, Yang Y . Update on management of ovarian hyperstimulation syndrome. Taiwan J Obstet Gynecol. 2011; 50(1):2-10. DOI: 10.1016/j.tjog.2011.01.014. View